223 related articles for article (PubMed ID: 17598453)
21. Dysregulation of GIMAP genes in non-small cell lung cancer.
Shiao YM; Chang YH; Liu YM; Li JC; Su JS; Liu KJ; Liu YF; Lin MW; Tsai SF
Lung Cancer; 2008 Dec; 62(3):287-94. PubMed ID: 18462827
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.
Osada S; Kanematsu M; Imai H; Goshima S
Hepatogastroenterology; 2008; 55(82-83):544-9. PubMed ID: 18613405
[TBL] [Abstract][Full Text] [Related]
23. MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.
Morello S; Olivero M; Aimetti M; Bernardi M; Berrone S; Di Renzo MF; Giordano S
J Cell Physiol; 2001 Dec; 189(3):285-90. PubMed ID: 11748586
[TBL] [Abstract][Full Text] [Related]
24. Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.
Volm M; Koomägi R; Efferth T; Mattern J
Anticancer Res; 2002; 22(4):2321-4. PubMed ID: 12174921
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer.
Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E
Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.
Wislez M; Rabbe N; Marchal J; Milleron B; Crestani B; Mayaud C; Antoine M; Soler P; Cadranel J
Cancer Res; 2003 Mar; 63(6):1405-12. PubMed ID: 12649206
[TBL] [Abstract][Full Text] [Related]
27. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma.
Graff L; Castrop F; Bauer M; Höfler H; Gratzl M
Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
[TBL] [Abstract][Full Text] [Related]
29. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
Onimaru Y; Tsukasaki K; Murata K; Imaizumi Y; Choi YL; Hasegawa H; Sugahara K; Yamada Y; Hayashi T; Nakashima M; Taguchi T; Mano H; Kamihira S; Tomonaga M
Int J Oncol; 2008 Oct; 33(4):697-703. PubMed ID: 18813782
[TBL] [Abstract][Full Text] [Related]
30. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.
Kammula US; Kuntz EJ; Francone TD; Zeng Z; Shia J; Landmann RG; Paty PB; Weiser MR
Cancer Lett; 2007 Apr; 248(2):219-28. PubMed ID: 16945480
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
32. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.
McDoniels-Silvers AL; Nimri CF; Stoner GD; Lubet RA; You M
Clin Cancer Res; 2002 Apr; 8(4):1127-38. PubMed ID: 11948124
[TBL] [Abstract][Full Text] [Related]
33. Expression of bone morphogenetic proteins in human lung carcinomas.
Langenfeld EM; Bojnowski J; Perone J; Langenfeld J
Ann Thorac Surg; 2005 Sep; 80(3):1028-32. PubMed ID: 16122479
[TBL] [Abstract][Full Text] [Related]
34. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.
Tsuta K; Kozu Y; Mimae T; Yoshida A; Kohno T; Sekine I; Tamura T; Asamura H; Furuta K; Tsuda H
J Thorac Oncol; 2012 Feb; 7(2):331-9. PubMed ID: 22198430
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor levels in liver and blood, and post-operative liver cell proliferation in patients with benign and malignant liver tumors after partial hepatectomy.
Dłuzniewska J; Zolich D; Polański J; Zajac L; Sitkiewicz D; Łukomska B
Med Sci Monit; 2002 Oct; 8(10):CR690-6. PubMed ID: 12388921
[TBL] [Abstract][Full Text] [Related]
36. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
Perner S; Wagner PL; Soltermann A; LaFargue C; Tischler V; Weir BA; Weder W; Meyerson M; Giordano TJ; Moch H; Rubin MA
J Pathol; 2009 Jan; 217(1):65-72. PubMed ID: 18932182
[TBL] [Abstract][Full Text] [Related]
37. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
38. The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes.
Berrieman HK; Smith L; O'Kane SL; Campbell A; Lind MJ; Cawkwell L
Cancer; 2005 Apr; 103(7):1415-9. PubMed ID: 15700269
[TBL] [Abstract][Full Text] [Related]
39. Bovine hepatocyte growth factor and its receptor c-Met: cDNA cloning and expression analysis in the mammary gland.
Yamaji D; Kimura K; Watanabe A; Kon Y; Iwanaga T; Soliman MM; Ahmed MM; Saito M
Domest Anim Endocrinol; 2006 Mar; 30(3):239-46. PubMed ID: 16207523
[TBL] [Abstract][Full Text] [Related]
40. SEL1L expression in non-small cell lung cancer.
Ferrero S; Falleni M; Cattaneo M; Malferrari G; Canton C; Biagiotti L; Maggioni M; Nosotti M; Coggi G; Bosari S; Biunno I
Hum Pathol; 2006 May; 37(5):505-12. PubMed ID: 16647946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]